Bionanotechnology News

RSS

New Report on Global Biochips and Nanobiotechnology-Based Nano-Arrays Market

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering.

From Research and Markets 6 Oct 2014

Professor Chris Toumazou Earns 2014 Faraday Medal for Semiconductor DNA Sequencing Technology

DNA Electronics (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for sepsis, announces today that its founder, Chairman and CEO Professor Chris Toumazou FRS, FREng, FMEDSci, FIET, FIEEE, FCGI, FRSM has been awarded the UK Institution of Engineering and Technology (IET)’s highest honour, the 2014 Faraday Medal.

3 Oct 2014

Two Finnish Life Science Companies Launch Upcon Upconverting Nanoparticle System

The life science field has seen numerous detection technologies come and go over the years. Some are shooting stars and others become the golden standard. Photon upconversion is a novel detection technology that has raised much enthusiasm among researchers during recent years.

3 Oct 2014

Superior Hybrid Gold Nanoparticle Cardiac Patch for Tissue Engineering

Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue engineering.

1 Oct 2014

NSF Nano-Biosensing Program Awarded Grant to Develop Smart Bioanalytical Systems

A team of researchers from Clarkson University and the University of Missouri have secured a grant from the National Science Foundation for their work in nano-biosensing.

1 Oct 2014

UCLA Re-Engineers Antibiotics to Enhance Activity Against Persister Cells

We face an urgent global health problem because scientists are not developing new antibiotics as fast as bacteria are developing antibiotic resistance.

30 Sep 2014

UNITAID Report on Tuberculosis Cites NanoLogix Detection Technology

NanoLogix Inc., an innovative biotechnology company in Northeastern Ohio announces that UNITAID, based in Geneva, Switzerland and hosted by the World Health Organization (WHO), on Friday published their Tuberculosis diagnostics technology and market landscape – 3rd edition. NanoLogix's sandwiched-membrane BNP rapid testing technology for tuberculosis is cited on pages 17 and 37 of the report.

From NanoLogix 30 Sep 2014

Researchers Develop New Technology to Inject RNA Carried by Lipidoid Nanoparticles

MIT engineers have devised a way to rapidly test hundreds of different drug-delivery vehicles in living animals, making it easier to discover promising new ways to deliver a class of drugs called biologics, which includes antibodies, peptides, RNA, and DNA, to human patients.

30 Sep 2014

Supersensitive Nanoprobe Sensor Enables Extremely Early Detection of Cancers

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville (UAH) in collaboration with The Joint School of Nanoscience and Nanoengineering (JSNN) in Greensboro, NC.

30 Sep 2014

Study Sheds New Light on Mechanism of Platelet Formation

Platelets are an expensive biomedical commodity. These microscopic cells that come to the rescue when our blood vessels need to be repaired cannot be frozen and are stable for only three to five days at room temperature.

29 Sep 2014